Dupixent (dupilumab)
Atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis
ApprovedCommercial
Key Facts
Indication
Atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis
Phase
Approved
Status
Commercial
Company
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a premier biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company has built a diversified portfolio of FDA-approved treatments and maintains a robust pipeline across oncology, immunology, ophthalmology, and other therapeutic areas. Regeneron's proprietary VelociSuite technologies, including VelocImmune mice and advanced manufacturing capabilities, enable rapid drug discovery and development. With multiple billion-dollar commercial products and strong financial performance, Regeneron ranks among the most successful biotech companies globally.
View full company profile